Upgrade to SI Premium - Free Trial

Wolfe Research Upgrades Celldex Therapeutics (CLDX) to Outperform

March 23, 2026 5:40 AM
(Updated - March 23, 2026 5:43 AM EDT)

Wolfe Research analyst Andy Chen upgraded Celldex Therapeutics (NASDAQ: CLDX) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments Hot Upgrades Upgrades